`
Wednesday, 16 August 2017

Australia News

  • Telstra health expands Asia presence

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2015

    Singapore: Australia's largest telecommunication and technology company, Telstra health, announced several key contract wins and implementations of hospital electronic medical record system...Read more

  • Telstra acquires UK-based healthcare firm

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 27 Mar, 2015

    Singapore: Australia-based Telstra healthcare has recently acquired a UK-based health analytics company, Dr Foster in a deal estimated to be worth between $40 million to $50 million. In add...Read more

  • A re-think on site staff competency training required

    Australia |  Opinion | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2013

    When drugs are trialed in patients, they move into a clinical setting in which the busy routine care of patients, rather than the conduct of drug trials, is usually the main preoccupation...Read more

  • Redefining Sleep Disorder Therapy

    Australia |  Analysis | By BioSpectrum Bureau | 0 Comment | 06 Jul, 2015

    Singapore: RESMED, Australia Chairman: Dr Peter C FarrellRevenue: $1437 mnBusiness: Manufacturing devices for sleep disordersResmed, a global name in medical devices for managing sleep-dis...Read more

  • EndoBarrier Therapy wins BioSpectrum product award

    Australia |  Influencers | By Vipul Murarka | 0 Comment | 15 Mar, 2013

    Diabetes has emerged as a major concern in Asia Pacific and companies are making a beeline to develop treatments for it. ASX-listed GI Dynamics has developed a novel treatment, called EndoB...Read more

  • Patrys gets US patent for antibody PAT-LM1

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2013

    Singapore: United States Patent Office has issued official "Letters Patent" on a key patent in the PAT-LM1 family; US patent 8,562,995 entitled "Neoplasm specific antibodies and uses thereo...Read more

  • Cellmid to supply diagnostic antibodies to Fujikura

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2013

    Singapore: Cellmid has signed an important option agreement with listed Japanese company Fujikura Kasei, a major supplier of latex particles used in medical diagnostics. Under the terms-o...Read more

  • Cure for drug addiction found

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 16 Aug, 2012

    Singapore: A team of researchers from the University of Adelaide and a team from the University of Colorado Boulder have found, for the first time, that blocking an immune receptor called T...Read more

  • Strong clinical trial infrastructure puts Australia in a strong position

    Australia |  Opinion | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2013

    Australia's strong history of quality and experience in clinical research is well known, and whilst being a comparatively mature market, Australia is a young country whose clinical resear...Read more

  • Wollongong university and AB SCIEX to advance lipid research

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2012

    Singapore: At the 19th annual International Mass Spectrometry Conference (IMSC), AB SCIEX and the University of Wollongong (UOW) announced a research partnership to develop lipid analysis ...Read more

  • Malaria vaccine may be a reality soon!

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 18 Mar, 2015

    Singapore: A vaccine for malaria may soon be a reality as Melbourne researchers have made a significant discovery about how the body's immune system fights the infection. Researchers at the...Read more

  • Britian's AMCo acquires Australian pharma company

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2015

    Singapore: Britain drugmaker AMCo recently announced the acquisition of pharmaceutical company, Boucher and Muir (BNM). Set up in 1957, BNM is an Australia-based specialty pharma company wi...Read more

  • MiReven micro RNA 'miR-7-5p' inhibits melanoma

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 13 Feb, 2013

    Singapore: MiReven, an Australian micro RNA (miRNA) company that is involved in commercializing discoveries from the Western Australian Institute for Medical Research (WAIMR) on the anti-ca...Read more

  • Australian Synchrotron to use Bluechiip technology

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 17 May, 2012

    Singapore: The Australian Synchrotron will use Bluechiip Limited's technology for protein crystallography tracking and automation. The Australian Synchrotron, one of the world's leading sci...Read more

  • BSA-CMR Survey: Asian CROs optimistic in a gloomy pharma market

    Australia |  Analysis | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013

    Over the past four years, BioSpectrum Asia in association with CyberMedia Research (CMR) has been capturing the key broad trends in pharmaceutical clinical and contract research organizat...Read more

  • Patrys' cancer diagnostic gets Australian govt grant

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2013

    Singapore: Australia based clinical stage biotechnology company Patrys' scientific collaborators at Macquarie University, Sydney, have been awarded a $427,510 Australian government grant to...Read more

  • GI Dynamics trims 10 percent workforce

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 15 Dec, 2014

    Singapore: GI Dynamics, a medical device company developing treatments for type 2 diabetes and obesity, has decided to axe its workforce by approximately 10 percent, in a restructuring stra...Read more

  • C-Pulse always keeps heart failure at bay

    Australia |  Influencers | By Vipul Murarka | 0 Comment | 01 Nov, 2012

    Dealing with the common diseases in an innovative manner is becoming a trend these days and not surprisingly, Australia is playing a crucial role in this. Sunshine Heart, a US-based company...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls